We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CYTO-205

News List

Cytocom Receives IND for CYTO-205 Trial for COVID-19 americanpharmaceuticalreview
March 23, 2021
Cytocom announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of ...
Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy contractpharma
March 17, 2021
Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of SARS-CoV-2.
Cytocom submits IND application to conduct Phase II Covid-19 drug trial pharmaceutical-technology
February 19, 2021
Cytocom has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA), with updated protocols, to begin a Phase II clinical trial of CYTO-205 for treating Covid-19.